FINANCIAL PERIOD DATA REFRESH REQUIRED
Select the Refresh button on the Summary or Disclosure tab

Registration number: 15871645

Brunswick Surgery Ltd

Profit and Loss Account for the Period from 2 August 2024 to 31 August 2025

The company has not traded during the period. During this period, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

Brunswick Surgery Ltd

(Registration number: 15871645)
Balance Sheet as at 31 August 2025

	Note	2025 £
Current assets
Debtors	3	8
Capital and reserves
Called up share capital	4	8
Shareholders' funds		8

For the financial period ending 31 August 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the Board on 10 July 2026 and signed on its behalf by:
 

......................................... Dr Paul Dhillon Director

......................................... Usha Ganeshalingam Director

......................................... Henry William Attard Director

Brunswick Surgery Ltd

(Registration number: 15871645)
Balance Sheet as at 31 August 2025

......................................... Dr Vaishali Nathan Director

Brunswick Surgery Ltd

Notes to the Unaudited Financial Statements for the Period from 2 August 2024 to 31 August 2025

1	General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Surbiton Health Centre, Ewell Road,
Surbiton,
Surrey
United Kingdom
KT6 6EZ

These financial statements were authorised for issue by the Board on 10 July 2026.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Debtors

Brunswick Surgery Ltd

Notes to the Unaudited Financial Statements for the Period from 2 August 2024 to 31 August 2025

Current	2025 £
Other debtors	8
	8

4	Share capital

Allotted, called up and fully paid shares

	2025
	No.	£
Ordinary Shares of £1 each	4	4
Ordinary A Shares of £1 each	1	1
Ordinary B Shares of £1 each	1	1
Ordinary C Shares of £1 each	1	1
Ordinary D Shares of £1 each	1	1
	8	8